Carlyle Group Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001527166

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 16 positions · Total reported value $8.36B · Top-10 concentration 100.0% · Updated 2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

Turnover: 21.1% · 0 new · 1 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.3% · vs SPY -18.4% · Prev Value $10.00B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.8% · vs SPY -6.0% · Latest Value $8.36B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Carlyle Group Inc. disclosed 16 equity positions with a combined reported value of $8.36B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were MDLN ($6.49B), SARO ($1.81B), PHAT ($25.53M). By sector, the heaviest allocations are Health Care 78.0%, Industrials 21.6%. Versus the prior quarter, allocation shifted toward Health Care (+3.8pp) and away from Industrials (-3.7pp).

Versus the prior quarter, Carlyle Group Inc. opened 0 new positions, trimmed 1 and fully exited 3, a turnover rate of 21.1% of positions. The portfolio's overlap with the prior quarter was 84% of names.

Of the 3 positions fully exited versus the prior quarter, the largest were GETY ($5.36M), QTTB ($769.02K), REPX ($530.39K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • GETY GETTY IMAGES HLDGS INC · prev qtr: $5.36M
  • QTTB Q32 BIO INC · prev qtr: $769.02K
  • REPX RILEY EXPLORATION PERMIAN IN · prev qtr: $530.39K

Insider Transactions (Form 4)

Latest Carlyle Group Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

The Carlyle Group was founded in 1987 in Washington, DC by Bill Conway, Dan D'Aniello and David Rubenstein and is one of the largest alternative asset managers in the world. It listed on Nasdaq (CG) in 2012.

Firm Snapshot

It runs three segments: Global Private Equity, Global Credit and Carlyle AlpInvest, its private-funds and secondaries solutions business. The firm describes its model as connecting people, ideas and capital across one network.

Harvey Schwartz has been CEO since 2023.

  • Headquarters: WASHINGTON, DC, United States
  • SEC registration: 801-52462 (status: Approved), registered 1996-08-06
  • Regulatory AUM (Form ADV): $200.75B as of 2026-07-07
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 314 private funds, of which 1 hedge funds

Portfolio Structure

  • 16 positions · $8.36B reported value (Q3 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MDLN (MEDLINE INC) at 77.6%
  • Average position size: $522.59M

Sector Tilt

  • Health Care 78.0%
  • Industrials 21.6%
  • Information Technology 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 added, 1 reduced, 3 exited
  • 13 positions unchanged

Reading the 13F

The 13F is a rounding error at Carlyle: most assets are unlisted company equity, private credit and fund interests that 13F never captures. What appears here — listed vehicles and CLO-related holdings — is a side sleeve.

The firm background and strategy notes are written by HoldingsHub editors from public sources; holdings, trading and Form ADV figures come from the firm's public SEC filings. Not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund maintained a concentrated portfolio (top-10 holdings = 99.94% of total value) with a heavy tilt toward Health Care (77.94%) and Industrials (21.62%). No new positions were added, and the only reduction was a 28.0% QoQ share cut in INVH, suggesting selective profit-taking or reduced confidence in residential real estate. 2. Key moves: - Reduced: INVH (-28.0% shares, weight fell 0.05pp). - Added: HOOD (+85.2% shares, weight unchanged at 0.01%, likely a small tactical increase). 3. Portfolio structure: Highly concentrated and active, with extreme sector bias (Health Care/Industrials dominate). Low diversification (16 positions) indicates high conviction or risk appetite. 4. Per-holding one-liner: - MDLN: MEDLINE INC (Health Care, medical supplies) - SARO: STANDARDAERO INC (Industrials, aerospace MRO) - PHAT: PHATHOM PHARMACEUTICALS INC (Health Care, biopharma) - PONY: PONY AI INC (Technology, autonomous driving) - INVH: INVITATION HOMES INC (Financials, single-family rentals) - SPRB: SPRUCE BIOSCIENCES INC (Health Care, biotech) - FWRD: FORWARD AIR CORP (Industrials, logistics) - ACET: ADICET BIO INC (Health Care, oncology biotech) - HOOD: ROBINHOOD MKTS INC (Financials, retail trading) - DNUT: KRISPY KREME INC (Consumer Staples, food retail) 5. Style summary: Concentrated, sector-biased fund with minimal changes, favoring Health Care/Industrials and trimming exposure to residential real estate.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-14 07:15

Sector Allocation

Health Care 78.0%
Industrials 21.6%
Technology 0.2%
Financials 0.2%
Energy 0.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 187.08M $6.49B 77.64%
77.64%
Hold
2 84.59M $1.81B 21.60%
21.60%
Hold
3 3.50M $25.53M 0.30%
0.30%
Hold
4 2.36M $15.45M 0.18%
0.18%
Hold
5 477.50K $12.57M 0.15%
0.15%
Reduce
6 38.62K $1.88M 0.02%
0.02%
Hold
7 107.21K $1.64M 0.02%
0.02%
Hold
8 184.29K $1.32M 0.02%
0.02%
Hold
9 8.77K $986.29K 0.01%
0.01%
Add
10 340.75K $977.95K 0.01%
0.01%
Hold
11 269.89K $735.46K 0.01%
0.01%
Hold
12 2.34M $719.77K 0.01%
0.01%
Hold
13 1.07M $618.39K 0.01%
0.01%
Hold
14 52.92K $437.67K 0.01%
0.01%
Add
15 1.85K $435.43K 0.01%
0.01%
Hold
16 93.73K $384.30K 0.01%
0.01%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 80% R 80% F1 80% (modelled on 2026-Q2; 8/10 hit)

Historical Backtest (11 quarters)

Avg precision 81% · recall 81% · F1 81% · avg rank error 1.8 · Top-10 turnover 18%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 90% 90% 90% QDEL · GTM · SLNO · VTRU · GETY · VRNA · GDS · PHAT · HLVX · VERA QDEL · GTM · SLNO · VTRU · VRNA · GETY · PHAT · JSPR · HLVX · GDS
2024-Q2 90% 90% 90% QDEL · GTM · SLNO · VTRU · VRNA · GETY · PHAT · HLVX · JSPR · GDS QDEL · GTM · SLNO · GDS · PHAT · VRNA · GETY · HLVX · JSPR · QTTB
2024-Q3 70% 70% 70% QDEL · GTM · SLNO · GDS · PHAT · VRNA · GETY · HLVX · JSPR · QTTB QDEL · SLNO · GTM · PHAT · QTTB · GETY · JSPR · INVH · SPWR · SMHI
2024-Q4 60% 60% 60% QDEL · SLNO · GTM · PHAT · QTTB · GETY · JSPR · INVH · SPWR · SMHI SARO · SLNO · WRD · PONY · PHAT · JSPR · GETY · INVH · CUBE · SMHI
2025-Q1 90% 90% 90% SARO · SLNO · WRD · PONY · PHAT · JSPR · GETY · INVH · CUBE · SMHI SARO · SLNO · WRD · PHAT · PONY · INVH · GETY · CUBE · SMHI · EM
2025-Q2 80% 80% 80% SARO · SLNO · WRD · PHAT · PONY · INVH · GETY · CUBE · SMHI · JSPR SARO · SLNO · PHAT · PONY · INVH · GETY · CUBE · JSPR · EM · HLVX
2025-Q3 70% 70% 70% SARO · SLNO · PHAT · PONY · INVH · GETY · CUBE · JSPR · EM · HLVX SARO · PONY · PHAT · SPRB · INVH · GETY · CUBE · FWRD · JSPR · ACET
2025-Q4 80% 80% 80% SARO · PONY · PHAT · SPRB · INVH · GETY · CUBE · FWRD · JSPR · ACET MDLN · SARO · PHAT · PONY · INVH · GETY · CUBE · QTTB · SPRB · FWRD
2026-Q1 100% 100% 100% MDLN · SARO · PHAT · PONY · INVH · CUBE · GETY · QTTB · SPRB · FWRD MDLN · SARO · PHAT · PONY · INVH · CUBE · QTTB · GETY · SPRB · FWRD
2026-Q2 80% 80% 80% MDLN · SARO · PHAT · PONY · INVH · CUBE · QTTB · GETY · SPRB · FWRD MDLN · SARO · PHAT · INVH · PONY · GETY · SPRB · SPWR · ACET · FWRD
2026-Q3 ★ 80% 80% 80% MDLN · SARO · PHAT · INVH · PONY · GETY · ACET · SPRB · SPWR · DNUT MDLN · SARO · PHAT · PONY · INVH · SPRB · FWRD · ACET · HOOD · DNUT

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-12. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-12 Trading days31 Holdings4 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-12, and will update as prices arrive.

Portfolio return+21.35%Buy & hold
QQQ synthetic benchmark-11.15%Liquidity weighted
Excess return+32.50%vs benchmark
Barra annualised vol54.8%Model estimate
Realised vol58.1%Annualised in window
Weighted beta0.48Raw exposure
Factor / specific risk31% / 69%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)76.988.9100.8112.7124.610-0110-2211-12Carlyle Group Inc.QQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+21.35%Disclosed long book
QQQ synthetic benchmark-11.15%Liquidity-weighted constituents
Model universe, equal weight+2.04%Opportunity-cost reference
Excess return+32.50%Portfolio − benchmark
Arithmetic return sum+21.25%Difference vs compounded is the cross term
Weighted raw beta0.48Weighted holding betas
Realised volatility (annualised)58.14%Daily returns in window
Barra model volatility (annualised)54.76%Factor + specific
Factor share of variance30.7%Barra factors
Specific share of variance69.3%Stock residuals
Reported value$6.51B13F long US equity

2. Return attribution

The +21.25% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -0.79% -3.7%
Momentum & Growth 3 +1.76% 8.3%
Volatility & Tail Risk 7 -7.99% -37.6%
Industry 12 +9.44% 44.4%
Specific 1 +18.83% 88.6%
Return attribution (style + industry, %)-10.2-5.1+0.0+5.1+10.2Short-term Reversal-0.32Growth-0.70Kurtosis-0.74Amihud Illiquidity+0.76Size+1.42Mid Cap+1.43Residual Volatility+1.64Beta-1.97Momentum+2.78Skewness+4.38Turnover-4.57Leverage (Downside Vol)-5.38Historical Volatility-6.22Health Care+9.44
Factor Type Exposure Factor return Contribution Share of |return|
Specific Specific — — +18.83% 88.6%
Health Care Industry +1.00 +9.47% +9.44% 44.4%
Skewness Style -0.92 -4.77% +4.38% 20.6%
Momentum Style -0.84 -3.32% +2.78% 13.1%
Residual Volatility Style +0.76 +2.15% +1.64% 7.7%
Mid Cap Style -0.74 -1.92% +1.43% 6.7%
Size Style -0.74 -1.93% +1.42% 6.7%
Amihud Illiquidity Style +2.52 +0.30% +0.76% 3.6%
Max Drawdown Style -0.30 -1.01% +0.30% 1.4%
Liquidity Style -0.78 -0.20% +0.16% 0.8%
Short-term Reversal Style -0.28 +1.12% -0.32% -1.5%
Growth Style -0.47 +1.50% -0.70% -3.3%
Kurtosis Style -0.12 +6.17% -0.74% -3.5%
Beta Style -0.40 +4.92% -1.97% -9.3%
Turnover Style +1.05 -4.35% -4.57% -21.5%
Leverage (Downside Vol) Style +1.77 -3.05% -5.38% -25.3%
Historical Volatility Style +0.63 -9.82% -6.22% -29.2%

3. Risk attribution

Annualised volatility is 54.76%; factor risk explains 30.7% of variance and specific risk 69.3%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-74.9-37.4+0.0+37.4+74.9Skewness-2.86Residual Volatility-1.00Short-term Reversal+0.68Mid Cap+0.72Turnover+0.98Growth+1.33Liquidity+1.53Beta+1.57Momentum+1.78Historical Volatility+3.51Amihud Illiquidity+6.95Health Care+7.18Leverage (Downside Vol)+7.20Specific+69.32
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 69.3% +37.96% 38.0%
Leverage (Downside Vol) Style +1.77 7.2% +3.94% 3.9%
Health Care Industry +1.00 7.2% +3.93% 3.9%
Amihud Illiquidity Style +2.52 7.0% +3.80% 3.8%
Historical Volatility Style +0.63 3.5% +1.92% 1.9%
Momentum Style -0.84 1.8% +0.97% 1.0%
Beta Style -0.40 1.6% +0.86% 0.9%
Liquidity Style -0.78 1.5% +0.84% 0.8%
Growth Style -0.47 1.3% +0.73% 0.7%
Turnover Style +1.05 1.0% +0.54% 0.5%
Mid Cap Style -0.74 0.7% +0.40% 0.4%
Short-term Reversal Style -0.28 0.7% +0.37% 0.4%
Size Style -0.74 0.6% +0.33% 0.3%
Max Drawdown Style -0.30 0.3% +0.17% 0.2%
Kurtosis Style -0.12 0.2% +0.12% 0.1%
Residual Volatility Style +0.76 -1.0% -0.55% -0.6%
Skewness Style -0.92 -2.9% -1.57% -1.6%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.3-0.20.81.82.9Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.74 +2.10 -2.84
Non-linear Size +0.23 +1.68 -1.45
Mid Cap -0.74 +0.13 -0.87
Beta -0.40 +1.29 -1.70
Momentum -0.84 +0.72 -1.55
Short-term Reversal -0.28 -0.64 +0.36
Residual Volatility +0.77 -0.40 +1.17
Historical Volatility +0.63 +0.86 -0.23
Liquidity -0.78 +0.11 -0.90
Amihud Illiquidity +2.52 +1.16 +1.36
Turnover +1.05 +0.21 +0.85
Growth -0.47 +0.58 -1.05
Leverage (Downside Vol) +1.77 +0.14 +1.62
Skewness -0.92 +0.24 -1.16
Kurtosis -0.12 +0.21 -0.33
Max Drawdown -0.30 -0.08 -0.21

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.019.949.979.8109.7Communication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsInformation TechnologyHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Health Care 99.7% 1.7% +21.50% +9.50% +19.51% +0.21% +11.76% +21.28%
Information Technology 0.2% 73.6% -28.01% -16.67% +4.60% -8.35% +8.32% +12.20%
Communication Services 0.0% 2.6% +0.00% -12.15% +0.05% +0.32% -0.32% +0.32%
Utilities 0.0% 0.8% +0.00% +10.14% -0.16% -0.08% +0.08% -0.08%
Consumer Staples 0.0% 0.8% +0.00% +15.33% -0.22% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +5.93% -1.44% -0.52% +0.52% -0.52%
Industrials 0.0% 11.1% +0.00% +7.87% -2.03% -0.87% +0.87% -0.87%
Total +20.22% -9.47% +21.40% +32.16%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
MDLN MEDLINE INC Health Care 99.74% +21.50% +21.44% Hold
PONY PONY AI INC Information Technology 0.24% -27.83% -0.07% Hold
HOOD ROBINHOOD MKTS INC Financials 0.01% -24.82% -0.00% Add
NBIS NEBIUS GROUP N.V. Information Technology 0.01% -34.42% -0.00% Hold
Contribution rank Symbol Sector Weight Return Contribution
1 MDLN Health Care 99.74% +21.50% +21.44%
2 NBIS Information Technology 0.01% -34.42% -0.00%
3 HOOD Financials 0.01% -24.82% -0.00%
4 PONY Information Technology 0.24% -27.83% -0.07%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-12 (31 trading days), the reported portfolio returned +21.35%, versus -11.15% for the QQQ synthetic benchmark — an excess of +32.50%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +9.44%, Skewness +4.38%, Momentum +2.78%; the largest drags came from Historical Volatility -6.22%, Leverage (Downside Vol) -5.38%, Turnover -4.57%. Specific (stock-level) return contributed +18.83%.
  3. Risk attribution: Barra model volatility is 54.76% annualised; factor risk explains 31% of variance and specific risk 69%. The largest factor risk sources are Leverage (Downside Vol) 7.2%, Health Care 7.2%, Amihud Illiquidity 7.0%.
  4. Style tilt: size -0.74, momentum -0.84, volatility +0.63, liquidity -0.78; the weighted raw beta is 0.48. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.0 pp), the largest underweight is Information Technology (-73.4 pp). Allocation contributed +20.22%, selection -9.47% and interaction +21.40%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Carlyle Group Inc. buy in 2026-Q3?

In its 2026-Q3 13F filing, Carlyle Group Inc. reported 16 equity positions worth $8.36B in aggregate; its largest disclosed positions were MDLN ($6.49B), SARO ($1.81B), PHAT ($25.53M).

How large is Carlyle Group Inc.'s portfolio?

Carlyle Group Inc. reported $8.36B of long equity holdings across 16 positions as of 2026-Q3. Top-10 holdings account for 100.0% of reported value.

What is Carlyle Group Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/carlyle/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →